BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1045 related articles for article (PubMed ID: 18755653)

  • 1. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].
    Martel P; Capdet J; Méry E; Zerdoud S; Ferron G; Rafii A; Roché H; Querleu D
    Bull Cancer; 2008; 95(7):763-72. PubMed ID: 18755653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node.
    Schrenk P; Konstantiniuk P; Wölfl S; Bogner S; Haid A; Nemes C; Jagoutz-Herzlinger M; Redtenbacher S
    Br J Surg; 2005 Jun; 92(6):707-13. PubMed ID: 15810047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sentinel node biopsy without systematic axillary dissection: study about 1000 procedures].
    Giard S; Chauvet MP; Houpeau JL; Baranzelli MC; Carpentier P; Fournier C; Belkacemi Y; Bonneterre J
    Gynecol Obstet Fertil; 2005 Apr; 33(4):213-9. PubMed ID: 15894205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS; van der Heiden-van der Loo M; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
    Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S
    Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
    J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].
    Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J
    Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis.
    Houvenaeghel G; Nos C; Giard S; Mignotte H; Esterni B; Jacquemier J; Buttarelli M; Classe JM; Cohen M; Rouanet P; Penault Llorca F; Bonnier P; Marchal F; Garbay JR; Fraisse J; Martel P; Fondrinier E; Tunon de Lara C; Rodier JF
    Eur J Surg Oncol; 2009 Jul; 35(7):690-5. PubMed ID: 19046847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer.
    Tan YY; Wu CT; Fan YG; Hwang S; Ewing C; Lane K; Esserman L; Lu Y; Treseler P; Morita E; Leong SP
    Breast J; 2005; 11(5):338-43. PubMed ID: 16174155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic examination of sentinel lymph nodes in breast cancer by a single haematoxylin-eosin slide versus serial sectioning and immunocytokeratin staining: clinical implications.
    Groen RS; Oosterhuis AW; Boers JE
    Breast Cancer Res Treat; 2007 Sep; 105(1):1-5. PubMed ID: 17221160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of selected breast cancer patients with micrometastasis or isolated tumor cells in sentinel node biopsy and no completion axillary lymph node dissection.
    Meretoja TJ; Vironen JH; Heikkilä PS; Leidenius MH
    J Surg Oncol; 2010 Sep; 102(3):215-9. PubMed ID: 20740577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognosis after sentinel node biopsy in malignant melanoma].
    Lock-Andersen J; Horn J; Sjøstrand H
    Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
    Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
    Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different?
    Zakaria S; Pantvaidya G; Reynolds CA; Grant CS; Sterioff S; Donohue JH; Farley DR; Hoskin TL; Degnim AC
    Surgery; 2008 May; 143(5):641-7. PubMed ID: 18436012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?
    Galimberti V; Botteri E; Chifu C; Gentilini O; Luini A; Intra M; Baratella P; Sargenti M; Zurrida S; Veronesi P; Rotmensz N; Viale G; Sonzogni A; Colleoni M; Veronesi U
    Breast Cancer Res Treat; 2012 Feb; 131(3):819-25. PubMed ID: 21468637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Feasibility of the sentinel node biopsy in breast cancer in case of histological multifocality diagnosis].
    Bézu C; Coutant C; Antoine M; Moutafoff C; Guillo E; Daraï E; Rouzier R; Uzan S
    Gynecol Obstet Fertil; 2009; 37(7-8):604-10. PubMed ID: 19577499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.